首页 | 本学科首页   官方微博 | 高级检索  
     

白念珠菌耐药的分子机制研究进展
引用本文:乔建军,刘伟,李若瑜. 白念珠菌耐药的分子机制研究进展[J]. 微生物学通报, 2007, 34(2): 0393-0396
作者姓名:乔建军  刘伟  李若瑜
作者单位:北京大学第一医院皮肤科北京大学真菌和真菌病研究中心,北京,100034
基金项目:国家自然科学基金;教育部留学回国人员科研启动基金
摘    要:近年来,免疫受损人群不断增多,该人群念珠菌病发病率呈上升趋势。随着抗真菌药物的广泛应用,临床分离到的白念珠菌耐药株增多,有关白念珠菌对抗真菌药物的耐药机制的研究又有了进一步的进展。就白念珠菌对唑类、多烯类、5-氟胞嘧啶、棘白菌素类等抗真菌药物的耐药机制方面的研究进展,作了介绍。

关 键 词:白念珠菌  抗真菌药物  耐药
文章编号:0253-2654(2007)02-0393-04
修稿时间:2006-12-02

Molecular Resistance Mechanisms of Candida albicans to Antifungal Agents
QIAO Jian-Jun,LIU Wei and LI Ruo-Yu. Molecular Resistance Mechanisms of Candida albicans to Antifungal Agents[J]. Microbiology China, 2007, 34(2): 0393-0396
Authors:QIAO Jian-Jun  LIU Wei  LI Ruo-Yu
Affiliation:Department of Dermatology, Research Center for Medical Mycology, Peking University First Hospital, Beijing 100034
Abstract:In recent years,with the increasing of immunocompromised patients in clinical practice,invasive candidiasis has been increased accordingly. Although several antifungal drugs,including polyenes,azoles,5-flucytosine,and echinocandins,have been used widely to treat invasive candidiasis,the treatment failure that caused by the resistance of Candida albicans to these antifungal drugs have been reported widely. Here,we reviewed the molecular mechanisms of resistance to azoles,polyenes,5-flucytosine,and echinocandins,such that to provide an update on these issues.
Keywords:Candida albicans  Antifungal drugs  Resistance mechanisms
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《微生物学通报》浏览原始摘要信息
点击此处可从《微生物学通报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号